CHMP2A and glioblastoma: We observed that low CHMP2A is associated with slightly increased (but not statistically significant) survival in GBM (Supplemental Fig. 3a), while the survival benefit of low CHMP2A expression is statistically significant in HNSCC (Supplemental Fig. 3b).